Hamasy A, Hussain A, Mohammad D, Wang Q, Sfetcovici M, Nore B
Sci Rep. 2025; 15(1):814.
PMID: 39755731
PMC: 11700165.
DOI: 10.1038/s41598-024-83962-8.
Zhang G, Sun N, Li X
Front Oncol. 2024; 14:1406759.
PMID: 39575431
PMC: 11578954.
DOI: 10.3389/fonc.2024.1406759.
Eshaq A, Flanagan T, Hassan S, Al Asheikh S, Al-Amoudi W, Santourlidis S
Cancers (Basel). 2024; 16(15).
PMID: 39123481
PMC: 11311543.
DOI: 10.3390/cancers16152754.
Dangelmaier C, Vari H, Vajipayajula D, Elzoheiry M, Wright M, Iyer A
Platelets. 2024; 35(1):2369766.
PMID: 38904212
PMC: 11322839.
DOI: 10.1080/09537104.2024.2369766.
Singh P, Dangelmaier C, Vari H, Tsygankov A, Kunapuli S
Platelets. 2023; 34(1):2249549.
PMID: 37661351
PMC: 10502920.
DOI: 10.1080/09537104.2023.2249549.
Cathepsin K inhibition induces Raptor destabilization and mitochondrial dysfunction via Syk/SHP2/Src/OTUB1 axis-mediated signaling.
Seo S, Woo S, Kwon T
Cell Death Dis. 2023; 14(6):366.
PMID: 37330581
PMC: 10276854.
DOI: 10.1038/s41419-023-05884-z.
Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases.
Li M, Wang P, Zou Y, Wang W, Zhao Y, Liu M
Heliyon. 2023; 9(5):e15625.
PMID: 37180910
PMC: 10172877.
DOI: 10.1016/j.heliyon.2023.e15625.
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Kling M, Kesherwani V, Mishra N, Alexander G, McIntyre E, Ray S
J Exp Clin Cancer Res. 2022; 41(1):321.
PMID: 36357906
PMC: 9650837.
DOI: 10.1186/s13046-022-02530-y.
Small-molecule screening identifies Syk kinase inhibition and rutaecarpine as modulators of macrophage training and SARS-CoV-2 infection.
John S, Singh A, Sun J, Pierre M, Alsalih L, Lipsey C
Cell Rep. 2022; 41(1):111441.
PMID: 36179680
PMC: 9474420.
DOI: 10.1016/j.celrep.2022.111441.
Tumor cell SYK expression modulates the tumor immune microenvironment composition in human cancer via TNF-α dependent signaling.
Aguirre-Ducler A, Gianino N, Villarroel-Espindola F, Desai S, Tang D, Zhao H
J Immunother Cancer. 2022; 10(7).
PMID: 35868661
PMC: 9315908.
DOI: 10.1136/jitc-2022-005113.
Single-cell analysis of skin immune cells reveals an Angptl4-ifi20b axis that regulates monocyte differentiation during wound healing.
Wee W, Low Z, Ooi C, Henategala B, Lim Z, Yip Y
Cell Death Dis. 2022; 13(2):180.
PMID: 35210411
PMC: 8873364.
DOI: 10.1038/s41419-022-04638-7.
Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment.
Chen X, Wang Z, Han S, Wang Z, Zhang Y, Li X
Cell Death Dis. 2021; 12(12):1123.
PMID: 34853322
PMC: 8636632.
DOI: 10.1038/s41419-021-04403-2.
The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance.
Narayanan S, Wu Z, Wang J, Ma H, Acharekar N, Koya J
Int J Biol Sci. 2021; 17(10):2652-2665.
PMID: 34326700
PMC: 8315011.
DOI: 10.7150/ijbs.61229.
Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy.
Yiu W, Chan K, Chan L, Leung J, Lai K, Tang S
Front Physiol. 2021; 12:650888.
PMID: 33790807
PMC: 8006276.
DOI: 10.3389/fphys.2021.650888.
Comparison of SYK Signaling Networks Reveals the Potential Molecular Determinants of Its Tumor-Promoting and Suppressing Functions.
Buffard M, Naldi A, Freiss G, Deckert M, Radulescu O, Coopman P
Biomolecules. 2021; 11(2).
PMID: 33670716
PMC: 7923165.
DOI: 10.3390/biom11020308.
Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells.
Lamb D, Rust A, Rudisch A, Gluxam T, Harrer N, Machat H
Oncotarget. 2020; 11(14):1257-1272.
PMID: 32292575
PMC: 7147091.
DOI: 10.18632/oncotarget.27545.
Role of spleen tyrosine kinase in liver diseases.
Kurniawan D, Storm G, Prakash J, Bansal R
World J Gastroenterol. 2020; 26(10):1005-1019.
PMID: 32205992
PMC: 7081001.
DOI: 10.3748/wjg.v26.i10.1005.
The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex.
Kassouf T, Larive R, Morel A, Urbach S, Bettache N, Marcial Medina M
Cancers (Basel). 2019; 11(12).
PMID: 31817924
PMC: 6966528.
DOI: 10.3390/cancers11121974.
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro.
Tummler C, Dumitriu G, Wickstrom M, Coopman P, Valkov A, Kogner P
Cancers (Basel). 2019; 11(2).
PMID: 30744170
PMC: 6406899.
DOI: 10.3390/cancers11020202.
Expression of Syk and MAP4 proteins in ovarian cancer.
Zhang S, Deen S, Storr S, Yao A, Martin S
J Cancer Res Clin Oncol. 2019; 145(4):909-919.
PMID: 30737623
PMC: 6435630.
DOI: 10.1007/s00432-019-02856-9.